Glenmark said clinical trials of the Covid-19 drug have begun and more than 10 leading government and private hospitals in India are being enrolled for the study. It estimates the study completion by July or August this year. Glenmark Pharmaceuticals said on Tuesday it has initiated clinical trials in India of antiviral drug favipiravir, seen as a potential treatment for the coronavirus disease (Covid-19), for which it received approval from